Similar documents
ๆญฏ1.PDF

์ œ8ํšŒ ์ „๋ฌธ์•ฝ์‚ฌ ์ž๊ฒฉ์‹œํ—˜ ์ผ์ • ๊ณต๊ณ  ๋ฐ ๋…ธ์ธ์•ฝ๋ฃŒ ๋ถ„๊ณผ ์‹ ์„ค ์•Œ๋ฆผ hwp

294~303ร‡รยผรบยบยธยฐรญ1ยฟร€ยฟยนยผร›


ยพรทยนยซยฐยณยผยฑ1รƒร–รรถยฟยต

ยพรทยนยซยฐยณยผยฑ1ยผร•รรถยพร–

09รˆยซยผยฎยฟยต 5~152s

< D B4D9C3CAC1A120BCD2C7C1C6AEC4DCC5C3C6AEB7BBC1EEC0C720B3EBBEC8C0C720BDC3B7C2BAB8C1A4BFA120B4EBC7D120C0AFBFEBBCBA20C6F2B0A E687770>

ZNMMZTUCJDUV.hwp


1..

ยฑรจร€ยบยฟยตยณยปรรถ9-191ลก



์„œ๋ก  34 2

ํ™ฉ์ง€์›…

untitled


<B3EDB9AEC1FD5F3235C1FD2E687770>

YI Ggodme : The Lives and Diseases of Females during the Latter Half of the Joseon Dynasty as Reconstructed with Cases in Yeoksi Manpil (Stray Notes w

012์ž„์ˆ˜์ง„

Lumbar spine

์•ฝ์ˆ˜ํ„ฐ2ํ˜ธ์ตœ์ข…2-์›น์šฉ

Journal of Educational Innovation Research 2017, Vol. 27, No. 2, pp DOI: : Researc

๋…ธ์ธ์˜ํ•™ PDF

00์•ฝ์ œ๋ถ€๋ด„ํ˜ธc03้€žํ’š

์ €์ž‘์žํ‘œ์‹œ - ๋น„์˜๋ฆฌ - ๋ณ€๊ฒฝ๊ธˆ์ง€ 2.0 ๋Œ€ํ•œ๋ฏผ๊ตญ ์ด์šฉ์ž๋Š”์•„๋ž˜์˜์กฐ๊ฑด์„๋”ฐ๋ฅด๋Š”๊ฒฝ์šฐ์—ํ•œํ•˜์—ฌ์ž์œ ๋กญ๊ฒŒ ์ด์ €์ž‘๋ฌผ์„๋ณต์ œ, ๋ฐฐํฌ, ์ „์†ก, ์ „์‹œ, ๊ณต์—ฐ๋ฐ๋ฐฉ์†กํ• ์ˆ˜์žˆ์Šต๋‹ˆ๋‹ค. ๋‹ค์Œ๊ณผ๊ฐ™์€์กฐ๊ฑด์„๋”ฐ๋ผ์•ผํ•ฉ๋‹ˆ๋‹ค : ์ €์ž‘์žํ‘œ์‹œ. ๊ท€ํ•˜๋Š”์›์ €์ž‘์ž๋ฅผํ‘œ์‹œํ•˜์—ฌ์•ผํ•ฉ๋‹ˆ๋‹ค. ๋น„์˜๋ฆฌ. ๊ท€ํ•˜๋Š”์ด์ €์ž‘๋ฌผ์„์˜๋ฆฌ๋ชฉ์ ์œผ๋กœ์ด์šฉํ• 

Rheu-suppl hwp

ํ•œ๊ตญ์„ฑ์ธ์—์„œ์ดˆ๊ธฐํ™ฉ๋ฐ˜๋ณ€์„ฑ์งˆํ™˜๊ณผ ์—ฐ๊ด€๋œ์œ„ํ—˜์š”์ธ์—ฐ๊ตฌ

16(1)-3(๊ตญ๋ฌธ)(p.40-45).fm

04-๋‹ค์‹œ_๊ณ ์†์ฒ ๋„61~80p


Microsoft Word doc

ยพรทยนยซยฐยณยผยฑยปรงยทรŠยฟรธรยพร‡รŠ

PowerPoint Template

03-ร€รŒรยฆร‡รถ


ๆญฏ3์ดํ™”์ง„

Journal of Educational Innovation Research 2018, Vol. 28, No. 1, pp DOI: * A Analysis of

16(2)-7(p ).fm

21(1)-5(10-57)p fm

hwp

ฮณ

DBPIA-NURIMEDIA

ร€รŒรร–รˆรฑ.hwp

์ €์ž‘์žํ‘œ์‹œ - ๋น„์˜๋ฆฌ - ๋ณ€๊ฒฝ๊ธˆ์ง€ 2.0 ๋Œ€ํ•œ๋ฏผ๊ตญ ์ด์šฉ์ž๋Š”์•„๋ž˜์˜์กฐ๊ฑด์„๋”ฐ๋ฅด๋Š”๊ฒฝ์šฐ์—ํ•œํ•˜์—ฌ์ž์œ ๋กญ๊ฒŒ ์ด์ €์ž‘๋ฌผ์„๋ณต์ œ, ๋ฐฐํฌ, ์ „์†ก, ์ „์‹œ, ๊ณต์—ฐ๋ฐ๋ฐฉ์†กํ• ์ˆ˜์žˆ์Šต๋‹ˆ๋‹ค. ๋‹ค์Œ๊ณผ๊ฐ™์€์กฐ๊ฑด์„๋”ฐ๋ผ์•ผํ•ฉ๋‹ˆ๋‹ค : ์ €์ž‘์žํ‘œ์‹œ. ๊ท€ํ•˜๋Š”์›์ €์ž‘์ž๋ฅผํ‘œ์‹œํ•˜์—ฌ์•ผํ•ฉ๋‹ˆ๋‹ค. ๋น„์˜๋ฆฌ. ๊ท€ํ•˜๋Š”์ด์ €์ž‘๋ฌผ์„์˜๋ฆฌ๋ชฉ์ ์œผ๋กœ์ด์šฉํ• 

13์žฅ๋ฌธํ˜„(541~556)ok

๋‹ฌ์ƒ์‚ฐ์ด ์ดˆ์‚ฐ๋ชจ ๋ถ„๋งŒ์‹œ๊ฐ„์— ๋ฏธ์น˜๋Š” ์˜ํ–ฅ โ… . ์„œ ๋ก  โ…ก. ์—ฐ๊ตฌ๋Œ€์ƒ ๋ฐ ๋ฐฉ๋ฒ• ้” ์€ 23) ์˜ ไธน ๆบช ์— ์ตœ์ดˆ๋กœ ๊ธฐ ์žฌ๋œ ์ฒ˜๋ฐฉ์œผ๋กœ, ์— ๋ณต์šฉํ•˜๋ฉด ํ•œ ๋‹คํ•˜์—ฌ ๋‚œ์‚ฐ์˜ ์˜ˆ๋ฐฉ๊ณผ ๋ฐ, ๋“ฑ์— ๋„๋ฆฌ ํ™œ์šฉ๋˜์–ด ์™”๋‹ค. ้” ์€ ์ด ๆฏ’ ํ•˜๊ณ  ๋Š” ็”˜ ่‹ฆ ํ•˜์—ฌ ๆฐฃ, ๆฐฃ ๅฏฌ,, ็ต ์˜ ํšจ๋Šฅ์ด ์žˆ

ร‡รยผรบยบยธยฐรญ3ยฝร…ยปรณยนรŒ

( )Kju269.hwp

์ €์ž‘์žํ‘œ์‹œ - ๋น„์˜๋ฆฌ - ๋ณ€๊ฒฝ๊ธˆ์ง€ 2.0 ๋Œ€ํ•œ๋ฏผ๊ตญ ์ด์šฉ์ž๋Š”์•„๋ž˜์˜์กฐ๊ฑด์„๋”ฐ๋ฅด๋Š”๊ฒฝ์šฐ์—ํ•œํ•˜์—ฌ์ž์œ ๋กญ๊ฒŒ ์ด์ €์ž‘๋ฌผ์„๋ณต์ œ, ๋ฐฐํฌ, ์ „์†ก, ์ „์‹œ, ๊ณต์—ฐ๋ฐ๋ฐฉ์†กํ• ์ˆ˜์žˆ์Šต๋‹ˆ๋‹ค. ๋‹ค์Œ๊ณผ๊ฐ™์€์กฐ๊ฑด์„๋”ฐ๋ผ์•ผํ•ฉ๋‹ˆ๋‹ค : ์ €์ž‘์žํ‘œ์‹œ. ๊ท€ํ•˜๋Š”์›์ €์ž‘์ž๋ฅผํ‘œ์‹œํ•˜์—ฌ์•ผํ•ฉ๋‹ˆ๋‹ค. ๋น„์˜๋ฆฌ. ๊ท€ํ•˜๋Š”์ด์ €์ž‘๋ฌผ์„์˜๋ฆฌ๋ชฉ์ ์œผ๋กœ์ด์šฉํ• 

<5B31362E30332E31315D20C5EBC7D5B0C7B0ADC1F5C1F8BBE7BEF720BEC8B3BB2DB1DDBFAC2E687770>

11ยนรšยดรถยฑร”

่ซ›โ‘บ๋„ป?๊พฉ๋ฟฐๅช›?้บย€1?ฮผ์˜ฑ?๋ช„์ญ›

12รˆยซยฑรขยผยฑยฟรœ339~370

์ž๊ธฐ๊ณต๋ช…์˜์ƒ์žฅ์น˜(MRI) ์ž์žฅ์„ธ๊ธฐ์— ๋”ฐ๋ฅธ MRI ํ’ˆ์งˆ๊ด€๋ฆฌ ์˜์ƒ๊ฒ€์‚ฌ์˜ ๊ฐœ๋ณ„ํ•ญ๋ชฉ์ ์ˆ˜ ์‹คํƒœ์กฐ์‚ฌ A B Fig. 1. High-contrast spatial resolution in phantom test. A. Slice 1 with three sets of hole arr

182~187ร‡รยผรบยบยธยฐรญ7รƒร–ยผ๏ฟฝร€ยฑ

235~

DBPIA-NURIMEDIA

???? 1

(

<353420B1C7B9CCB6F52DC1F5B0ADC7F6BDC7C0BB20C0CCBFEBC7D120BEC6B5BFB1B3C0B0C7C1B7CEB1D7B7A52E687770>

Jkcs022(89-113).hwp

ํŒจ์…˜ ์ „๋ฌธ๊ฐ€ 293๋ช… ๋Œ€์ƒ ์•™์ผ€ํŠธ+์ „๋ฌธ๊ธฐ์ž๋‹จ ์„ ์ • Fashionbiz CEO Managing Director Creative Director Independent Designer

[ReadyToCameral]RUFยนรถร†ร›(CSTA02-29).hwp

ํ˜„๋Œ€ํŒจ์…˜์˜ ๋กœ๋งจํ‹ฑ ์ด๋ฏธ์ง€์— ๊ด€ํ•œ ์—ฐ๊ตฌ

ยพรทยนยซยฐยณยผยฑยปรงยทรŠ2รยครร–ยฟรธ

Abstract Background : Most hospitalized children will experience physical pain as well as psychological distress. Painful procedure can increase anxie

(JBE Vol. 21, No. 1, January 2016) (Regular Paper) 21 1, (JBE Vol. 21, No. 1, January 2016) ISSN 228

878 Yu Kim, Dongjae Kim ์ง€๋ง‰ ์šฉ๋Ÿ‰์ˆ˜์ค€๊นŒ์ง€๋„ ๋ฉˆ์ถค ๊ทœ์น™์ด ๋งŒ์กฑ๋˜์ง€ ์•Š์•„ ์‹œํ–‰์ด ์ข…๋ฃŒ๋˜์ง€ ์•Š๋Š” ๊ฒฝ์šฐ์—๋Š” MTD์˜ ์ถ”์ •์ด ๋ถˆ๊ฐ€ ๋Šฅํ•˜๋‹ค๋Š” ๋‹จ์ ์ด ์žˆ๋‹ค. ์ตœ๊ทผ ์ด SM๋ฐฉ๋ฒ•์˜ ๋‹จ์ ์„ ๋ณด์™„ํ•˜๊ธฐ ์œ„ํ•ด O Quigley ๋“ฑ (1990)์ด ์ œ์•ˆํ•œ CRM(Continu

6ร€รฅยตยถยผยบยฟยฌยฑยธยบรยพรŸ


#รˆยฒยฟรซยผยฎ

54 ํ•œ๊ตญ๊ต์œก๋ฌธ์ œ์—ฐ๊ตฌ์ œ 27 ๊ถŒ 2 ํ˜ธ, I. 1.,,,,,,, (, 1998). 14.2% 16.2% (, ), OECD (, ) % (, )., 2, 3. 3

์„œ๋ก 

DBPIA-NURIMEDIA

16(1)-4(๊ตญ๋ฌธ)(p.9-13).fm


<BABBB9AE2E687770>

UPMLOPEKAUWE.hwp

<B1B3B9DFBFF83330B1C7C1A631C8A35FC6EDC1FDBABB5FC7D5BABB362E687770>

DBPIA-NURIMEDIA

( )Kjhps043.hwp

<4D F736F F D20C0C7BEE0C7B0BAD0B7F9BAB8B0EDBCAD2E646F63>

๋ฏผ์†์ง€_์ด๊ฑด์šฑT ์ตœ์ข…

, ( ) 1) *.. I. (batch). (production planning). (downstream stage) (stockout).... (endangered). (utilization). *

WHO ์˜์ƒˆ๋กœ์šด๊ตญ์ œ์žฅ์• ๋ถ„๋ฅ˜ (ICF) ์—๋Œ€ํ•œ์ดํ•ด์™€๊ธฐ๋Šฅ์ ์žฅ์• ๊ฐœ๋…์˜ํ•„์š”์„ฑ ( ํ™ฉ์ˆ˜๊ฒฝ ) ๊Œ™ 127 ๋…ธ๋™์ •์ฑ…์—ฐ๊ตฌ ์ œ 4 ๊ถŒ์ œ 2 ํ˜ธ pp.127~148 c ํ•œ๊ตญ๋…ธ๋™์—ฐ๊ตฌ์› WHO ์˜์ƒˆ๋กœ์šด๊ตญ์ œ์žฅ์• ๋ถ„๋ฅ˜ (ICF) ์—๋Œ€ํ•œ์ดํ•ด์™€๊ธฐ๋Šฅ์ ์žฅ์• ๊ฐœ๋…์˜ํ•„์š”์„ฑํ™ฉ์ˆ˜๊ฒฝ *, (disabi

์žฅ์–‘์ˆ˜

.. IMF.. IMF % (79,895 ). IMF , , % (, 2012;, 2013) %, %, %

ePapyrus PDF Document

Pharmacotherapeutics Application of New Pathogenesis on the Drug Treatment of Diabetes Young Seol Kim, M.D. Department of Endocrinology Kyung Hee Univ

02ร‡รฃร€รŽร‡รฝ ~26ลก


ร†ยฏรรฝ1ร€รŒยผยฑยนรŽ

ร€รฅยพร–ยฟรยฐรญยฟรซ ยณยปรรถ

News Letter(6์›”).hwp

(JH)

09๊ตฌ์ž์šฉ(489~500)


์กฐ์‚ฌ์—ฐ๊ตฌ sampling error of polling sites and the additional error which comes from non-response, early voting and second stage sampling error of voters in

Transcription:

๋ณ‘์›์•ฝ์‚ฌํšŒ์ง€ (2010), ์ œ 27 ๊ถŒ์ œ 1 ํ˜ธ J. Kor. Soc. Health-Syst. Pharm., Vol. 27, No. 1, 64 ~ 71 (2010) ์—…๋ฌด๊ฐœ์„ ์‚ฌ๋ก€ Unit Dose System ์„ํ†ตํ•œ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜์—…๋ฌดํ™œ๋™ ๊ฐ€ํ†จ๋ฆญ๋Œ€ํ•™๊ต์„œ์šธ์„ฑ๋ชจ๋ณ‘์›์•ฝ์ œ๋ถ€, ๊ฐ€ํ†จ๋ฆญ๋Œ€ํ•™๊ต์˜๊ณผ๋Œ€ํ•™์•ฝ๋ฆฌํ•™๊ต์‹ค * Work activities of a clinical pharmacist through a Unit Dose System implementation Ji Yun Woo0, Sung Hee Kwon, Hyun Joon Ku, Young Hyun Han, Jeong Yi Yoon, Ok yeon Han, Hyen-oh La* Department of Pharmac, Seoul St. Mary 's Hospital, 505 Banpo-Dong, Seocho-Ku, Seoul, 137-040, KOREA Abstract : In a hospital pharmacy, traditional drug distribution system (TDS) was a combination of patient prescription system (PPS) and floor stock system (FSS). But, these systems can increase more medication error, drugs discarded, and wasteful nursing time. Therefore, we introduced Unit Dose System (UDS), which provides drugs for 24hr from noon to next day noon, in a trial ward from May 2008 and a clinical pharmacist managed patient medication profile and dispensing. To make a quality index for UDS extension, we evaluated administration-related improvements and analyzed medication intervention by a clinical pharmacist. Rate of regular medication order increased from 40.3% to 60.0% which implied the efficiency of pharmacy work flow. Nurses administration time was decreased as much as 44.4% from average 322 minutes to average 179 minutes after UDS implementation. Medication error was none in UDS compared to one case of wrong time administration in TDS. Efficiency of stock management was improved by reducing floor stock down by 96.1%, the floor stock remained was 4 kinds of parenteral analgesics. Dispensing time for UDS bin filling and checking was required average 42 minutes. A clinical pharmacist performed medication intervention through management of patient medication profile (PMP) after rounding with physicians. A pharmacist also did patient educations, clinical pharmacokinetic consultation service, and drug identification. The clinical service was concentrated to medication intervention by 37.5% which included adverse drug event (ADE) 23.6%, dosage 20.1%, and drug recommendation 14.6%. In conclusion, we achieved medication order process setting for UDS, decrease in nurses administration time. A clinical pharmacist, who is - 64 -

์šฐ์ง€์œค : Unit Dose System ์„ํ†ตํ•œ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜์—…๋ฌดํ™œ๋™ a essential model of UDS implement, performed a critical role in pharmaceutical care and communication with other health care provider. [Key words] Unit Dose System, UDS, clinical pharmacist, medication intervention ์„œ๋ก ์ž…์›ํ™˜์ž์˜ํˆฌ์•ฝ์€์กฐ์ œ๋œ์•ฝ์„๋ณ‘๋™์œผ๋กœ์šด๋ฐ˜ํ•œ์ดํ›„ํˆฌ์•ฝํ•˜๋Š” PPS(Patient Prescription System) ์™€๋ณ‘๋™๋น„ํ’ˆ์•ฝ์„๋น„์น˜ํ•˜์—ฌ์ฒ˜๋ฐฉ์ด๋‚˜์˜ค๋ฉด๊ฐ„ํ˜ธ์‚ฌ๊ฐ€์ ์ ˆํžˆ์„ ํƒ, ์žฌํฌ์žฅํ•˜์—ฌํˆฌ์•ฝํ•˜๋Š” FSS(Flow Stock System) ๋ฅผ์‚ฌ์šฉํ•˜๊ณ ์žˆ๋Š”๋ฐ, ์ด๋Š”์žฌํฌ์žฅํ•˜๋Š”๊ณผ์ •์—์„œ์˜ํˆฌ์•ฝ๊ณผ์˜ค์œจ์ด์ƒ์Šน๋˜๊ณ ํ๊ธฐ๋˜๋Š”์•ฝํ’ˆ์ด์ฆ๊ฐ€๋˜๋ฉฐ๊ฐ„ํ˜ธ์ธ๋ ฅ์ด๋‚ญ๋น„๋˜๋Š”๋“ฑ์˜๋ฌธ์ œ๊ฐ€๋ฐœ์ƒ๋˜์–ด์™”๋‹ค. ๋˜ํ•œ, ์ด๋Ÿฐํˆฌ์•ฝ์‹œ์Šคํ…œ์—์„œ๋Š”์•ฝ์‚ฌ๊ฐ€์‹ค์ œ์‹œํ–‰๋˜๋Š”ํˆฌ์•ฝ๋‚ด์šฉ, ๊ฒ€์‚ฌ๊ฒฐ๊ณผ๋“ฑ์—๊ทผ๊ฑฐ๋ฅผ๋‘”์•ฝ๋ฌผ์š”๋ฒ•์„ํ‰๊ฐ€ํ•˜๊ธฐ๊ฐ€์–ด๋ ค์šด์ƒํ™ฉ์œผ๋กœ์•ฝ์‚ฌ์—์˜ํ•ด๊ฐํ™˜์ž์˜ํˆฌ์•ฝ๋ ฅ์ดํˆฌ์•ฝ๊ณผ๋™์‹œ์—๊ธฐ๋ก๊ด€๋ฆฌ๋ ์ˆ˜์žˆ๋Š”์ƒˆ๋กœ์šดํˆฌ์•ฝ์‹œ์Šคํ…œ์—๋Œ€ํ•œํ•„์š”์„ฑ์ด์ œ๊ธฐ๋˜์–ด์™”๋‹ค. Unit Dose System( ์ดํ•˜ UDS) ์€ 1960๋…„๋Œ€์ค‘๋ฐ˜๋ฏธ๊ตญ์—์„œํˆฌ์•ฝ์˜๋ชจ๋“ ๋‹จ๊ณ„์—์„œ์•ฝ์—๋Œ€ํ•œ์ „๋ฌธ์ ์ง€์‹์ด์š”๊ตฌ๋˜์–ด์•ฝ์‚ฌ์˜์ฑ…์ž„ํ•˜์—๊ด€๋ฆฌํ•ด์•ผ๋˜๋Š”์ธ์‹๋ณ€ํ™”๋กœ์‹œ์ž‘๋˜์—ˆ์œผ๋ฉฐ์ดํ›„, ๊ฒฝ์ œ์„ฑ, ์•ˆ์ „์„ฑ, ํšจ์œจ์„ฑ์—์„œ๊ฐ€์žฅ์žฅ์ ์ด๋งŽ์€ํˆฌ์•ฝ์‹œ์Šคํ…œ์œผ๋กœํ‰๊ฐ€๋˜์–ด์™”๋‹ค. 1977๋…„ JACHO(Joint Commission on Accreditation of Healthcare Organizations) ์—์„œ๋Š”ํ‘œ์ค€์•ฝ์ œ์„œ๋น„์Šค๋กœ UDS๋ฅผ์ถ”์ฒœํ•˜์˜€๊ณ  1992๋…„์—๋Š” UDS ์‹œํ–‰๋ณ‘์›์ด์ „์ฒด์˜ 24% ์—๋ถˆ๊ณผํ•˜๋˜๊ฒƒ์ด 95% ๋กœ์ฆ๊ฐ€๋˜์—ˆ๋‹ค. ์šฐ๋ฆฌ๋‚˜๋ผ์—๋Š”์„œ์šธ๋Œ€ํ•™๊ต, ์‚ผ์„ฑ์„œ์šธ๋ณ‘์›, ์„œ์šธ์•„์‚ฐ๋ณ‘์›, ์™ˆ๋ ˆ์Šค์นจ๋ก€๋ณ‘์›๋“ฑ์—์„œ์‹œํ–‰ํ•˜๊ณ ์žˆ๋‹ค. 3) UDS๋Š”๋ชจ๋“ ์•ฝํ’ˆ์„ single unit ๋˜๋Š” unit dose package์˜ํˆฌ์•ฝ๊ฐ€๋Šฅํ•œํ˜•ํƒœ๋กœ๋ถ„๋ฐฐํ•˜์—ฌํˆฌ์•ฝํ•˜๋„๋กํ•˜๋Š”์‹œ์Šคํ…œ์œผ๋กœ, ํ•œ๋ฒˆ์— 24์‹œ๊ฐ„์ด๋‚ด์—์‚ฌ์šฉํ• ์•ฝํ’ˆ๋งŒ๊ณต๊ธ‰ํ•˜๋ฉฐ์•ฝ์‚ฌ์—์˜ํ•œ์•ฝ๋ ฅ์˜๊ฒ€ํ† ์™€ unit dose package, ์•ฝ์‚ฌ์˜ํˆฌ์•ฝ๊ด€๋ฆฌ๋“ฑ์˜ 3๊ฐ€์ง€๋ฅผ๊ธฐ ๋ณธ์š”์†Œ๋กœํ•œ๋‹ค 3). UDS๋Š”์•ฝ์‚ฌ์—์˜ํ•œํˆฌ์•ฝ๊ด€๋ฆฌ์‹œ์Šคํ…œ์œผ๋กœ, ๋ณธ์›์—์„œ๋Š” UDS ์‹ค์‹œ์‹œํ•ด๋‹น๋ณ‘๋™์˜์ฒ˜๋ฐฉ๋‚ด์šฉ๊ณผ์—…๋ฌดํ๋ฆ„์—๋Œ€ํ•œ๋ถ„์„์„๋ฐ”ํƒ•์œผ๋กœ์ตœ์ ์˜์•ฝ๋ฌผ์š”๋ฒ•์ด๋˜๋„๋ก์˜๋ฃŒ์ง„์—๊ฒŒ์ž๋ฌธ์—…๋ฌด๋ฅผ์ˆ˜ํ–‰ํ•˜๊ณ , ์•ฝ๋ฌผ์ •๋ณด๋ฅผ์ œ๊ณตํ•˜๋Š”๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์ œ๋„๋ฅผ์šด์˜ํ•˜์˜€๋‹ค. ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ๋Š” PMP(patient medication profile) ๋ฅผํ†ตํ•ด์„œ์•ฝ๋ฌผ์ƒํ˜ธ์ž‘์šฉ, ์•ฝ์šฉ๋Ÿ‰์˜์ ์ ˆ์„ฑ, ์•ฝ๋ฌผ๋ถ€์ž‘์šฉ๋ฐœํ˜„๋“ฑ์„์ž๋ฌธํ•˜๊ณ ์žˆ์œผ๋ฉฐ, ์•ฝ๋™ํ•™๋“ฑ์˜์ž„์ƒ์—…๋ฌด์™€๋ณต์•ฝ์ƒ๋‹ด๋“ฑ์„์ˆ˜ํ–‰ํ•จ์œผ๋กœ์จ์ „๋ฌธ์ ์ธ์ž„์ƒ์•ฝ์‚ฌ๋กœ์„œ์˜์—ญํ• ์„๋‹ด๋‹นํ•˜๊ณ ์žˆ๋‹ค. 7) ๋ณธ์—ฐ๊ตฌ๋Š”์‹œ๋ฒ”๋ณ‘๋™์˜ UDS์™€๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์‹œํ–‰์„ํ†ตํ•ดํˆฌ์•ฝ๊ด€๋ จ๊ฐœ์„ ์‚ฌํ•ญ์„๋„์ถœํ•˜๊ณ ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜์ฒ˜๋ฐฉ์ค‘์žฌ๋‚ด์šฉ์„๋ถ„์„ํ•˜์—ฌํ–ฅํ›„, ์ „๋ณ‘๋™ํ™•๋Œ€์‹œํ–‰์‹œ์—…๋ฌด์˜์งˆ์ง€ํ‘œ๋กœํ™œ์šฉํ•˜๊ณ ์ž์‹ค์‹œํ•˜์˜€๋‹ค. ์—ฐ๊ตฌ๋ฐฉ๋ฒ• 1. ์—ฐ๊ตฌ๋Œ€์ƒ๋ฐ๊ธฐ๊ฐ„๋ณธ์›์˜๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ๋Š” 2007๋…„ 7์›”๋ถ€ํ„ฐ์‹ ๊ฒฝ์™ธ๊ณผ๋ณ‘๋™์„๋Œ€์ƒ์œผ๋กœ์‹ค์‹œํ•˜์˜€๊ณ  UDS๋Š”๋™์ผ๋ณ‘๋™์„์‹œ๋ฒ”๋ณ‘๋™์œผ๋กœ 2008๋…„ 5์›”๋ถ€ํ„ฐ์‹ค์‹œํ•˜๊ณ ์žˆ์œผ๋ฉฐ์ด๊ธฐ๊ฐ„์„์—ฐ๊ตฌ๊ธฐ๊ฐ„์œผ๋กœํ•˜์˜€๋‹ค. 2. ํ‰๊ฐ€์ง€ํ‘œ 1) ํˆฌ์•ฝ๊ด€๋ จ๊ฐœ์„ ์‚ฌํ•ญ UDS๋Š” 24์‹œ๊ฐ„์ด๋‚ดํ•„์š”ํ•œ์•ฝํ’ˆ์„๊ณต๊ธ‰ํ•˜๋Š”์‹œ์Šคํ…œ์œผ๋กœ์ด๋ฅผ์œ„ํ•ด์„œ๋Š”์ •๊ทœ์ฒ˜๋ฐฉ์ค‘์‹ฌ์˜์ฒ˜๋ฐฉ๋ฐœํ–‰์ด์„ ํ–‰๋˜์–ด์•ผํ•˜๊ณ ์กฐ์ œ์™€ํˆฌ์•ฝ์ค€๋น„๋ฅผ์œ„ํ•ดํˆฌ์•ฝ์ ์šฉ์‹œ์ ์„์ ์‹ฌ์œผ๋กœํ•˜๋Š”์ฒ˜๋ฐฉํ”„๋กœ์„ธ์Šค์˜์ •๋ฆฝํ™”๊ฐ€์š” - 65 -

JKSHP, VOL. 27, NO.1 (2010) ๊ตฌ๋˜์—ˆ๋‹ค. ๋ณธ์›์˜ํˆฌ์•ฝ์ ์šฉ์‹œ์ ์€๊ฒฝ๊ตฌ์•ฝ์€์ ์‹ฌ๋ถ€ํ„ฐ, ์ฃผ์‚ฌ์ œ๋Š”์•„์นจ๋ถ€ํ„ฐ๋กœ์ด์›ํ™”๋˜์–ด์žˆ์—ˆ๊ณ , ์ด์—๋”ฐ๋ฅธ์•ผ๊ฐ„์˜์‘๊ธ‰์ฒ˜๋ฐฉ๋ฐœํ–‰๋“ฑ์ด๋ฌธ์ œ์‹œ๋˜์–ด์™”๋‹ค. UDS ์‹ค์‹œ์—์•ž์„œ์ฃผ์‚ฌ์ œ์ ์šฉ์‹œ์ ์„๊ฒฝ๊ตฌ์•ฝ์ œ์™€์ผ์›ํ™”์‹œ์ผœ์„œ๋ณ‘๋™ํˆฌ์•ฝ์‹œ๊ฐ„์—๋งž์ถ”์–ด์•ฝ์ด๋ณ‘๋™์—๋„๋‹ฌํ• ์ˆ˜์žˆ๋„๋กํ•˜์˜€๊ณ ์ด๋ฅผ์œ„ํ•ด๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ๊ฐ€์‹ ๊ฒฝ์™ธ๊ณผ์ฃผ์น˜์˜๋ฅผ๋Œ€์ƒ์œผ๋กœ์ฒ˜๋ฐฉ์ ์šฉ์‹œ์ ๋ฐ์ •๊ทœ์ฒ˜๋ฐฉ๋ฐœํ–‰์—๋Œ€ํ•ด์ง€์†์ ์ธ๊ต์œก์„์‹ค์‹œํ•˜์˜€๋‹ค. ์ •๊ทœ์ฒ˜๋ฐฉ๋ฐœํ–‰์œจ์€ UDS ์‹ค์‹œ์ „, ํ›„๊ฐ 5์ผ๊ฐ„์„์กฐ์‚ฌํ•˜์—ฌ๋ณ€ํ™”์œจ์„์ธก์ •ํ•˜์˜€์œผ๋ฉฐ, ๋น„ํ’ˆ์•ฝ์ œ๋Š”์‹ค์‹œํ›„์ƒˆ๋กœ์„ ์ •๋œ๋น„ํ’ˆ์•ฝ์ œ์™€๊ธฐ์กด์˜ํ’ˆ๋ชฉ์ˆ˜์™€๋น„์šฉ์„๋น„๊ตํ•˜์˜€๋‹ค. ๊ฐ„ํ˜ธํˆฌ์•ฝ๊ด€๋ จ์—…๋ฌด์‹œ๊ฐ„๋ณ€ํ™”๋Š”์‹ค์‹œ์ „, ํ›„ 3 ์ผ๊ฐ„ 3๋…„์ฐจ์ด์ƒ์˜๊ฐ„ํ˜ธ์‚ฌ๋ฅผ๋Œ€์ƒ์œผ๋กœ worksampling ๋ฐฉ๋ฒ•์„์‚ฌ์šฉํ•˜์—ฌ๊ทผ๋ฌด์ค‘์—…๋ฌด์‹œ๊ฐ„์„์ธก์ •ํ•˜์˜€๋‹ค. UDS์˜์‹œํ–‰์„ฑ๊ณผ๋ฅผํ‰๊ฐ€ํ•˜๋Š”๋ฐ์ค‘์š”ํ•œ์ง€ํ‘œ์ธํˆฌ์•ฝ๊ณผ์˜ค์œจ์˜๋ณ€ํ™”๋Š”์˜์‚ฌ์ฒ˜๋ฐฉ์—๋”ฐ๋ฅธํˆฌ์•ฝ๊ณผ์˜ค 6๊ฐœํ•ญ๋ชฉ์„์ •ํ•˜์—ฌ์‹ค์‹œ์ „, ํ›„ 2์ฃผ๊ฐ„์˜๊ฑด์ˆ˜๋ฅผ์กฐ์‚ฌํ•˜์˜€๋‹ค.( Table 1) 2) ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์—…๋ฌด๋ถ„์„๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜ UDS ์‹ค์‹œ์—๋”ฐ๋ฅธ์—…๋ฌด์‹œ๊ฐ„๋ณ€ํ™”๋Š”์ „, ํ›„ 3์ผ๊ฐ„ work-sampling ๋ฐฉ๋ฒ•์„์‚ฌ์šฉํ•˜์˜€ Table1. ํˆฌ์•ฝ๊ณผ์˜ค์กฐ์‚ฌํ•ญ๋ชฉ Omission ์ฒ˜๋ฐฉ๋œ์•ฝ์„ํˆฌ์—ฌํ•˜์ง€์•Š์€๊ฒฝ์šฐ Extra dose ์ฒ˜๋ฐฉ์—์—†๋Š”์•ฝ์„ํˆฌ์•ฝํ•œ๊ฒฝ์šฐ Wrong dose ์ฒ˜๋ฐฉ๋œ์•ฝ์šฉ๋Ÿ‰๋ณด๋‹ค๊ณผ๋‹ค๋˜๋Š”๊ณผ์†Œํˆฌ์•ฝํ•œ๊ฒฝ์šฐ Unordered dose ์ฒ˜๋ฐฉ์€ A ์•ฝ๋ฌผ์ด๋‚˜ B ์•ฝ๋ฌผ์„ํˆฌ์•ฝํ•œ๊ฒฝ์šฐ Wrong route ๊ฒฝ๋กœ์˜ค๋ฅ˜ Wrong dosage form ์ง€์ •๋œ dosage form๊ณผ๋‹ค๋ฅธ์•ฝ์„ํˆฌ์•ฝํ•œ๊ฒฝ์šฐํˆฌ์•ฝ์‹œ๊ฐ„์˜์˜ค๋ฅ˜ Wrong time ( ์ •๊ทœํˆฌ์•ฝ์‹œ๊ฐ„์—์„œ 60๋ถ„์ด์ƒ์˜์˜ค์ฐจ๋ฐœ์ƒ์‹œ ) ์œผ๋ฉฐ, ์ฒ˜๋ฐฉ์ค‘์žฌ๋‚ด์šฉ๋ถ„์„์€ 2007๋…„ 7์›”๋ถ€ํ„ฐ 2008 ๋…„ 9์›”๊นŒ์ง€๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜์ฒ˜๋ฐฉ์ค‘์žฌ์™€ 2008๋…„ 8์›”๋ถ€ํ„ฐ 9์›”๊นŒ์ง€๋ณ‘๋™์•ฝ๊ตญ์•ฝ์‚ฌ์˜์ฒ˜๋ฐฉ์ค‘์žฌ๋ฅผ๋น„๊ต๋ถ„์„, ๋น„๊ตํ•˜์˜€๋‹ค. ๊ฒฐ๊ณผ 1. ํˆฌ์•ฝ๊ด€๋ จ๊ฐœ์„ ์‚ฌํ•ญ 1) ์ฒ˜๋ฐฉํ”„๋กœ์„ธ์Šค์˜์ •๋ฆฝํ™”์‹ค์‹œ์ „์˜์ •๊ทœ์ฒ˜๋ฐฉ์€ 40.3%( ์ด 866๊ฑด์ค‘ 349๊ฑด ) Fig. 1 ์ •๊ทœ์ฒ˜๋ฐฉ๋ฐœํ–‰์œจ - 66 -

์šฐ์ง€์œค : Unit Dose System ์„ํ†ตํ•œ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜์—…๋ฌดํ™œ๋™ Table 2. ๋ณ‘๋™๋น„ํ’ˆ์•ฝ์ œ๋ณ€ํ™” ํ•ญ๋ชฉํ’ˆ๋ชฉ์ˆ˜๋น„์šฉ ( ์› ) UDS ์‹ค์‹œ์ „ UDS ์‹ค์‹œํ›„ ๋ณ€ํ™”์œจ 102 4 96.1% 6,801,829 7,932 Table 3. ๋ฐ˜ํ™˜๋œ๋ณ‘๋™๋น„ํ’ˆ์•ฝ์ œํ•ญ๋ชฉ (n=102) ๊ณ„์—ด ๊ฐ์—ผ์ฆ์น˜๋ฃŒ์ œ ๋‚ด๋ถ„๋น„๋ฐ๋Œ€์‚ฌ์ž‘์šฉ์•ฝ๋ฌผ * ์†Œํ™”๊ธฐ๊ณ„์ž‘์šฉ์•ฝ๋ฌผ์ˆœํ™˜๊ธฐ๊ณ„์ž‘์šฉ์•ฝ๋ฌผ์‹ ๊ฒฝ๊ณ„์ž‘์šฉ์•ฝ๋ฌผ ์กฐํ˜ˆ๊ธฐ๊ณ„์ž‘์šฉ์•ฝ๋ฌผํ•ด๋…์ œํ˜ธํก๊ธฐ๊ณ„์ž‘์šฉ์•ฝ๋ฌผ < ๊ณ„์—ด๋ถ„๋ฅ˜๋Š” CMC ์˜์•ฝํ’ˆ์ง‘ 10 ๊ฐœ์ •ํŒ์ฐธ์กฐ > * ์Šคํ…Œ๋กœ์ด๋“œ๋“ฑํ˜ธ๋ฅด๋ชฌ์ œ, ์ „ํ•ด์งˆ, ๊ฐ„์žฅ์šฉ์ œํฌํ•จ ๋งˆ์ทจ์ œ, ์ง„ํ†ต์ œ, ์†Œ์—ผ์ œ, ํ•ญ์ •์‹ ๋ณ‘์•ฝ๋ฌผ, ํ•ญ์ „๊ฐ„์ œ, ๊ทผ์œก์ด์™„์ œ๋“ฑ ์™ธ์šฉํก์ž…์ œ 4 ๊ฐ€์ง€ํฌํ•จ 99.8% ํ’ˆ๋ชฉ์ˆ˜ 36 12 9 14 11 7 6 7 ์ด์˜€๊ณ , ์‹ค์‹œํ›„ 60.0%(632๊ฑด์ค‘ 379๊ฑด ) ๋กœ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ์ด์—๋น„ํ•ด์ถ”๊ฐ€์ฒ˜๋ฐฉ๋ฐ์‘๊ธ‰์ฒ˜๋ฐฉ์€์‹ค์‹œ์ „๊ฐ๊ฐ 30.0%(260๊ฑด ), 25.9%(224๊ฑด ) ์—์„œ์‹ค์‹œํ›„ 19.6%(124๊ฑด ) 18%(114๊ฑด ) ์œผ๋กœ๊ฐ์†Œํ•˜์˜€๋‹ค (Fig. 1). ์ •๊ทœ์ฒ˜๋ฐฉ์ด์ฆ๊ฐ€ํ•˜๊ณ ์ถ”๊ฐ€๋ฐ์‘๊ธ‰์ฒ˜๋ฐฉ์˜๊ฐ์†Œ๋กœ๋‹น์ผ 24์‹œ๊ฐ„์ด๋‚ดํˆฌ์•ฝํ• ์•ฝ์˜๋Œ€๋ถ€๋ถ„์„ UDS ์‹œ์Šคํ…œ์„์ด์šฉํ•˜์—ฌํˆฌ์•ฝํ•จ์œผ๋กœ์จ์—…๋ฌดํšจ์œจ์„๊ธฐ๋Œ€ํ• ์ˆ˜์žˆ์—ˆ๋‹ค. ๋˜ํ•œํˆฌ์•ฝ์ ์šฉ์‹œ์ ์€๊ฒฝ๊ตฌ์ œ๋Š”์ ์‹ฌ๋ถ€ํ„ฐ, ์ฃผ์‚ฌ์ œ๋Š”์•„์นจ๋ถ€ํ„ฐ์‹ค์‹œํ•˜๋˜๊ฒƒ์„์ ์‹ฌ์ ์šฉ์œผ๋กœ์ผ์›ํ™”ํ•˜์—ฌ์‹ค์‹œํ•˜์˜€๋‹ค. 2) ๋ณ‘๋™๋น„ํ’ˆ์•ฝ์ œ๊ด€๋ฆฌ๋ณ‘๋™๋น„ํ’ˆ์•ฝ์ œ์˜ํ’ˆ๋ชฉ์ˆ˜๋Š”์‹ค์‹œ์ „ 102ํ’ˆ๋ชฉ์—์„œ์‹ค์‹œํ›„ํ•„์š”์‹œํˆฌ์•ฝํ•˜๋Š”์•ฝ์ œ์ธ์ง„ํ†ต์ œ 4ํ’ˆ๋ชฉ์œผ๋กœ๊ฐ์†Œํ•˜์˜€๊ณ  (96.1%), ๋น„์šฉ์€ 99.8% ๊ฐ€๊ฐ์†Œํ•˜์˜€๋‹ค (Table 2). ๋น„ํ’ˆ์•ฝ์ œ๋Š”๊ฐ์—ผ์ฆ์น˜๋ฃŒ์ œ๊ฐ€ 36ํ’ˆ๋ชฉ์œผ๋กœ๊ฐ€์žฅ๋งŽ์•˜์œผ๋ฉฐ, ์ˆœํ™˜๊ธฐ๊ณ„์•ฝ๋ฌผ์ด 14ํ’ˆ๋ชฉ, ๋‚ด๋ถ„๋น„๋ฐ๋Œ€์‚ฌ์ž‘์šฉ์•ฝ๋ฌผ์ด 12ํ’ˆ๋ชฉ, ๊ทธ๋ฆฌ๊ณ ์‹ ๊ฒฝ๊ณ„์ž‘์šฉ์•ฝ๋ฌผ์ด 11ํ’ˆ๋ชฉ๋“ฑ์ด์—ˆ๋‹ค. ๊ธฐํƒ€์†Œํ™”๊ธฐ๊ณ„์ž‘์šฉ์•ฝ๋ฌผ, ์กฐํ˜ˆ๊ธฐ๊ณ„์ž‘์šฉ์•ฝ๋ฌผ, ํ•ด๋…์ œ, ํ˜ธํก๊ธฐ๊ณ„์ž‘์šฉ์•ฝ๋ฌผ์ด๋ณ‘๋™๋น„ํ’ˆ์•ฝ์ œ์—ํฌํ•จ๋˜์–ด์žˆ์—ˆ๋‹ค (Table 3). ๋น„ํ’ˆ์•ฝ์ œ์˜๊ฐ์†Œ๋Š”์ฃผ์‚ฌ์ œ์ ์šฉ์‹œ์ ์„์ ์‹ฌ์œผ๋กœํ•˜์—ฌ์•„์นจํˆฌ์•ฝ Fig. 2 ๊ฐ„ํ˜ธํˆฌ์•ฝ๊ด€๋ จ์—…๋ฌด์‹œ๊ฐ„๋ณ€ํ™” - 67 -

JKSHP, VOL. 27, NO.1 (2010) ๋ถ„์ดํ•„์š”ํ•˜์ง€์•Š์Œ์—๊ธฐ์ธํ•œ๋‹ค๊ณ ๋ณผ์ˆ˜์žˆ๋‹ค. 3) ๊ฐ„ํ˜ธํˆฌ์•ฝ๊ด€๋ จ์—…๋ฌด์‹œ๊ฐ„๋ณ€ํ™”๊ฐ„ํ˜ธ์—…๋ฌด์ค‘ํˆฌ์•ฝ๊ด€๋ จ์—…๋ฌด์‹œ๊ฐ„์€ day๊ทผ๋ฌด์™€ evening ๊ทผ๋ฌด์‹œ์†Œ์š”๋˜๋Š”์‹œ๊ฐ„์„์ธก์ •ํ•˜์˜€๋Š”๋ฐ์‹ค์‹œ์ „ํ‰๊ท  322๋ถ„์—์„œ์‹ค์‹œํ›„ 179๋ถ„์œผ๋กœ 44.4% ์˜๊ฐ์†Œํšจ๊ณผ๋ฅผ๋‚˜ํƒ€๋‚ด์—ˆ๋‹ค. ์‹œ๊ฐ„๋Œ€๋ณ„๋กœ์—…๋ฌด์‹œ๊ฐ„๋ณ€ํ™”๋ฅผ๋ณด๋ฉด day์™€ evening์‹œ๊ฐ๊ฐ์‹ค์‹œ์ „ 155๋ถ„, 167 ๋ถ„์—์„œ์‹ค์‹œํ›„ 72๋ถ„, 107๋ถ„์œผ๋กœ๊ฐ์†Œํ•˜์˜€๋‹ค (Fig. 2). 5) ํˆฌ์•ฝ๊ณผ์˜ค๊ด€๋ฆฌํˆฌ์•ฝ๊ณผ์˜ค๋Š” UDS ์„ฑ๊ณผ๋ฅผ์œ„ํ•œ์ค‘์š”ํ•œ์ง€ํ‘œ๋กœ์˜์‚ฌ๊ฐ€์ฒ˜๋ฐฉ์„ํ•œ๋‚ด์šฉ์—๋Œ€ํ•œํˆฌ์•ฝ๊ณผ์˜ค๋ฅผ๊ธฐ์ค€์œผ๋กœํ‰๊ฐ€ํ•˜์˜€๋‹ค. ํ‰๊ฐ€ํ•ญ๋ชฉ์€์˜๋ฌด๊ธฐ๋ก์ง€์—์žˆ๋Š” 6๊ฐ€์ง€๋กœ์˜์‚ฌ์˜์ฒ˜๋ฐฉ์—๋ฒ—์–ด๋‚˜๋Š”๋ชจ๋“ ์•ฝ๋ฌผํˆฌ์•ฝ๋ˆ„๋ฝ, ์ฒ˜๋ฐฉ๋˜์ง€์•Š๋Š”์•ฝ, ํ•„์š”์ด์ƒ์˜์šฉ๋Ÿ‰ํˆฌ์•ฝ, ์ž˜๋ชป๋œ์šฉ๋Ÿ‰, ํˆฌ์—ฌ์‹œ๊ฐ์˜์ž˜๋ชป์œผ๋กœํ•˜์˜€๋‹ค. ์‹ค์‹œ์ „๋ฐœ์ƒ๋œํˆฌ์•ฝ๊ณผ์˜ค๊ฑด์ˆ˜๋Š” 1๊ฑด์œผ๋กœ wrong time์—์˜ํ•œํˆฌ์•ฝ๊ณผ์˜ค์˜€์œผ๋ฉฐ์‹ค์‹œํ›„์—๋Š”ํˆฌ์•ฝ๊ณผ์˜ค๊ฐ€๋ฐœ์ƒ๋˜์ง€์•Š์•˜๋‹ค. 4) ์กฐ์ œ๊ด€๋ จ์—…๋ฌด์‹œ๊ฐ„๋ณ€ํ™”์กฐ์ œ๊ด€๋ จ์—…๋ฌด์‹œ๊ฐ„์€๊ฒฝ๊ตฌ์ œ๋ฐ์ฃผ์‚ฌ์ œ๋ฅผํ™˜์ž๋ณ„์•ฝํ•จ์— fillingํ•˜๊ธฐ, ํ™˜์ž๋ณ„๊ฐ์‚ฌ์ง€๋ฅผ์ด์šฉํ•˜์—ฌ๊ฐ์‚ฌ๋ฅผ์œ„ํ•ดํ‰๊ท  42.6๋ถ„์˜์ถ”๊ฐ€์—…๋ฌด์‹œ๊ฐ„์ด๋ฐœ์ƒํ•˜์˜€๋‹ค. Table 4. ์•ฝ์‚ฌ์˜์—…๋ฌด๋ถ„๋ฅ˜์ฃผ์—…๋ฌด์กฐ์ œ๊ด€๋ จ์—…๋ฌด, ์•ฝ๋ ฅ๊ด€๋ฆฌ, ์ฒ˜๋ฐฉ์ค‘์žฌํ™œ๋™๋“ฑ๋ณด์กฐ์—…๋ฌด๊ต์œก, ํ•™์Šต, ์•ฝํ’ˆ๊ด€๋ฆฌ๋“ฑ์ž„์ƒ์—…๋ฌดํšŒ์ง„, ๋ณต์•ฝ์ƒ๋‹ด, ์•ฝํ’ˆ์‹๋ณ„์—…๋ฌด, TDM ์—…๋ฌด๊ธฐํƒ€๊ฐœ์ธ์‹œ๊ฐ„๋“ฑ 2. ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์—…๋ฌด๋ถ„์„ 1) ์•ฝ์‚ฌ์˜์—…๋ฌด์‹œ๊ฐ„๋ณ€ํ™”๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์‹ค์‹œ์ „์•ฝ์‚ฌ์˜์—…๋ฌด์‹œ๊ฐ„์€์กฐ์ œ๊ด€๋ จ์—…๋ฌด (65.6%) ๊ฐ€๊ฐ€์žฅ๋งŽ์€๋น„์ค‘์„์ฐจ์ง€ํ•˜์˜€๊ณ , ์ž„์ƒ์—…๋ฌด (16.7%), ๊ธฐํƒ€ ( ๊ต์œก, ํ•™์Šต๋ณด์กฐ์—…๋ฌด๊ฐ€ 14.6%(70 ๋ถ„ ) ์˜€๋‹ค. ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์‹ค์‹œํ›„์—๋Š”์ž„์ƒ์—…๋ฌด์—ํ• ๋‹น๋˜๋Š”์‹œ๊ฐ„์ด 52.1%(250๋ถ„ ) ๋กœ์ฆ๊ฐ€ํ•˜์˜€๊ณ , ๋ณด์กฐ์—…๋ฌด๊ฐ€ 37.5%(180๋ถ„ ), ์ฃผ์—…๋ฌด๊ฐ€ 8.3%(40๋ถ„ ) ๋กœ์กฐ์ œ๊ด€๋ จ์—…๋ฌด์—ํ• ๋‹น๋˜๋Š”์‹œ๊ฐ„์ด๊ฐ์†Œํ•˜์˜€๋‹ค (Fig. 3). ๊ตฌ์ฒด์ ์œผ๋กœ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜์—…๋ฌด๋ฅผ๋ถ„๋ฅ˜ํ•˜์—ฌ๋ณด๋ฉด์‹ ํ™˜๋ฐํ‡ด์›ํ™˜์ž๋ณต์•ฝ์ƒ๋‹ด, ์ž…์›ํ™˜์žํ•ญ์•”์ œ๋ณต์•ฝ์ƒ๋‹ด, ํ™˜์ž๋ณ„์•ฝ๋ ฅ๊ด€๋ฆฌ๋ฅผํ†ตํ•œ์ฒ˜๋ฐฉ์ค‘์žฌ, TDM ์—…๋ฌด, ์•ฝํ’ˆ์‹๋ณ„์—…๋ฌด, ์‹ ๊ทœ์•ฝ์ œ๋ฐํ”„๋กœํ† ์ฝœ์—๋Œ€ํ•œ์ž๋ฃŒ์ •๋ฆฌ๋“ฑ Fig. 3 ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜์—…๋ฌด์‹œ๊ฐ„๋ณ€ํ™” - 68 -

์šฐ์ง€์œค : Unit Dose System ์„ํ†ตํ•œ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜์—…๋ฌดํ™œ๋™ ์œผ๋กœ๋‚˜๋‰˜์–ด์ง„๋‹ค (Table 5). ์ž‘์šฉ, ์•ฝ๋ฌผ์ •๋ณด์ œ๊ณต, ํ•ญ์•”ํ”„๋กœํ† ์ฝœ๊ด€๋ฆฌ, ์ œํ˜•๋“ฑ์—๊ด€ํ•œ๊ฒƒ์ด์—ˆ๋‹ค. Table 5. ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜์—…๋ฌด์—…๋ฌดํ•ญ๋ชฉ์‹ ํ™˜๋ฐํ‡ด์›ํ™˜์ž๋ณต์•ฝ์ƒ๋‹ด์ž…์›ํ™˜์žํ•ญ์•”์ œ๋ณต์•ฝ์ƒ๋‹ดํ™˜์ž๋ณ„์•ฝ๋ ฅ๊ด€๋ฆฌ๋ฅผํ†ตํ•œ์ฒ˜๋ฐฉ์ค‘์žฌ TDM ์—…๋ฌด์•ฝํ’ˆ์‹๋ณ„์—…๋ฌด์‹ ๊ทœ์•ฝ์ œ๋ฐํ”„๋กœํ† ์ฝœ์—๋Œ€ํ•œ์ž๋ฃŒ์ •๋ฆฌ 2) ์ฒ˜๋ฐฉ์ค‘์žฌ๋‚ด์šฉ๋ถ„์„๋ณ‘๋™์•ฝ๊ตญ์•ฝ์‚ฌ์˜์ฒ˜๋ฐฉ์ค‘์žฌ๋Š”์šฉ๋Ÿ‰๊ด€๋ จ์ค‘์žฌ๊ฐ€ 67% ๋กœ๊ฐ€์žฅ๋งŽ์€๋ถ€๋ถ„์„์ฐจ์ง€ํ•˜์˜€๊ณ , ์ฝ”๋“œ 14%, ์ œํ˜• 11%, ๋™์ผ๊ณ„์—ด์ค‘๋ณต์•ฝ๊ด€๋ จ์ค‘์žฌ๊ฐ€ 8% ์˜€๋‹ค (Fig4). ๋ฐ˜๋ฉด, ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜์ฒ˜๋ฐฉ์ค‘์žฌ๋Š”๋ถ€์ž‘์šฉ (23.7%), ์šฉ๋Ÿ‰ (20.2%), ์•ฝ์ œ์ถ”์ฒœ (14.6%) ์ดํฐ๋น„์ค‘์„์ฐจ์ง€ํ•˜์˜€๊ณ , ์ด์™ธ์—๋„์•ฝ๋ฌผ์‚ฌ์šฉํ‰๊ฐ€ (9.0%), TDM ์ถ”์ฒœ (5.6%) ๋“ฑ๋‹ค์–‘ํ•œ์ค‘์žฌ๊ฐ€์ด๋ฃจ์–ด์กŒ๋‹ค. ์•ฝ๋ฌผ์‚ฌ์šฉํ‰๊ฐ€๋Š”์ฃผ๋กœํ•ญ์ƒ์ œ, ํ•ญ์ „๊ฐ„์ œ, ๋ถˆํ•„์š”์•ฝ์ œ์—๋Œ€ํ•œ๊ฒƒ์ด์—ˆ๋‹ค. ๊ธฐํƒ€ 14.2% ์—ํ•ด๋‹น๋˜๋Š”์ฒ˜๋ฐฉ์ค‘์žฌ๋Š”์•ฝ๋ฌผ์ƒํ˜ธ ๊ณ ์ฐฐ๋ณธ์›์˜์ฒ˜๋ฐฉ์‹œ์Šคํ…œ์€์ฒ˜๋ฐฉ์ž…๋ ฅ์‹œ์ „์‚ฐ์ž…๋ ฅ์˜๊ธฐ๋ณธ์„ค์ •์ด ์ถ”๊ฐ€์ฒ˜๋ฐฉ ์œผ๋กœ์ •ํ•ด์ ธ์žˆ์–ด์„œ์ •๊ทœ์ฒ˜๋ฐฉ๋„๋ชจ๋‘์ถ”๊ฐ€์ฒ˜๋ฐฉ์œผ๋กœ์ž…๋ ฅํ•˜๊ฒŒ๋˜๋Š”์‚ฌ๋ก€๊ฐ€๋งŽ์•˜์œผ๋ฉฐ์ฒ˜๋ฐฉ์˜๊ธฐ๋ณธ๊ฐœ๋…์˜๊ต์œก๋„๋ถ€์กฑํ•œํ˜„์‹ค์ด์—ˆ๋‹ค. UDS ์‹ค์‹œ๋ฅผ์œ„ํ•œ์ฒ˜๋ฐฉํ”„๋กœ์„ธ์Šค์ •๋ฆฝํ™”๊ณผ์ •์„์ง„ํ–‰ํ•˜๋ฉด์„œ์˜๋ฃŒ์ง„์—๋Œ€ํ•œ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์™€๊ฐ„ํ˜ธ์‚ฌ๋“ค์˜์ง€์†์ ์ธ๊ต์œก์œผ๋กœ๋ชจ๋“ ์•ฝ์ œ๋ฅผ์ •๊ทœ์ฒ˜๋ฐฉ์ค‘์‹ฌ์œผ๋กœ์ž…๋ ฅํ•˜๋Š”์ธ์‹๋ณ€ํ™”์˜๊ณ„๊ธฐ๊ฐ€๋˜์–ด์ •๊ทœ์ฒ˜๋ฐฉ๋ฐœํ–‰์œจ์ด์‹ค์‹œ์ „ 40.3% ์—์„œ์‹ค์‹œํ›„ 60% ๋กœ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ๋˜ํ•œ, ๊ด€๋ จ๋ถ€์„œํ˜‘์˜๋ฅผํ†ตํ•ด์ „๋ฐ˜์ ์ธ์ฒ˜๋ฐฉํ”„๋กœ์„ธ์Šค๋ฅผ์ ๊ฒ€ํ•˜๋ฉด์„œ์ฒ˜๋ฐฉํ๋ฆ„์˜๋‹จ๊ณ„๋ณ„๋ฌธ์ œ์ ์„๋ฐœ๊ฒฌํ•˜๊ณ ์˜๋ฃŒ์ง„๊ณผ์ง€์†์ ์ธ์—…๋ฌดํ˜‘์˜๋ฅผํ†ตํ•ด๊ฐœ์„ ํ• ์ˆ˜์žˆ๋Š”๊ธฐํšŒ๊ฐ€๋˜์—ˆ๋‹ค. ํˆฌ์•ฝ์ ์šฉ์‹œ์ ์˜๊ฒฝ์šฐ, ๊ฒฝ๊ตฌ์ œ๋Š”์ ์‹ฌ๋ถ€ํ„ฐ์ ์šฉ์ด๋‚˜์ฃผ์‚ฌ์ œ๋Š”์•„์นจํˆฌ์•ฝ์œผ๋กœ๋˜์–ด์žˆ์–ด์„œ๋ณ‘๋™์—์„œ๋Š”๋‹น์ผํˆฌ์—ฌ๋ถ„์„์•ผ๊ฐ„์—์ค€๋น„ํ•จ์—๋”ฐ๋ผ์‘๊ธ‰์ฒ˜๋ฐฉ์ฆ๊ฐ€์˜์š”์ธ์ด๋˜์–ด์™”๋‹ค. UDS ์‹œ์ž‘์œผ๋กœ์ฃผ์‚ฌ์ œ์ ์šฉ์‹œ์ ์„์ ์‹ฌํˆฌ์•ฝ์œผ๋กœ๋ณ€๊ฒฝ์œผ๋กœ์ฃผ์‚ฌ์ œ์˜์•„์นจํˆฌ์—ฌ๋ถ„์ดํ•„์š”์—†์Œ์—๋”ฐ๋ผ์•ฝ์ œ๋ฅผ์ •๋ฆฌํ•˜๊ฒŒ๋˜์–ดํ•ญ์ƒ์ œ๋ฅผํฌํ•จํ•œ ๋ณ‘๋™์•ฝ๊ตญ์•ฝ์‚ฌ n=36 ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ n=144 Fig. 4 ์ฒ˜๋ฐฉ์ค‘์žฌ๋‚ด์šฉ๋ถ„์„ - 69 -

JKSHP, VOL. 27, NO.1 (2010) 102ํ’ˆ๋ชฉ์—์„œํ•„์š”์‹œํˆฌ์—ฌ์•ฝ์ œ 4ํ’ˆ๋ชฉ์œผ๋กœ๊ฐ์†Œํ•˜์˜€๋‹ค. UDS๋Š”๋ณ‘์›์šด์˜๋ฐฉ๋ฒ•์ƒ unit dose ํฌ์žฅํ˜•ํƒœ, ๋ณ‘๋™ํˆฌ์•ฝ์‹œ๊ฐ„์—๋งž๋Š”์•ฝ์šด๋ฐ˜, ๊ฐ„ํ˜ธ์ธ๋ ฅ๋ฐฐ์น˜์™€ํˆฌ์•ฝ๊ธฐ๋ก๋ฐฉ๋ฒ•๋“ฑ์—์„œ์—ฌ๋Ÿฌ๊ฐ€์ง€ํ˜•ํƒœ๋กœ์šด์˜๋ ์ˆ˜์žˆ๋Š”๋ฐ, 1)~4), 7) ๋ณธ์›์—์„œ๋Š”์ •๊ทœ์ฒ˜๋ฐฉ์—์˜ํ•œ 1์ผํˆฌ์—ฌ๋Ÿ‰์˜๊ฒฝ๊ตฌ์ œ์™€์ฃผ์‚ฌ์•ฝ์ œ๋ฅผํ™˜์ž๋ณ„์•ฝํ•จ์—๋ถ„๋ฐฐํ•˜์˜€๋Š”๋ฐ๊ฒฝ๊ตฌ์•ฝ์ œ๋Š”๊ฐ์•ฝ๋ฌผ๋‹จ์œ„์˜ํฌ์žฅ์ด์•„๋‹Œ๋™์‹œํˆฌ์—ฌ๋˜๋Š”์•ฝ์ œ๋ฅผ์กฐ์ œํ•˜์—ฌ๋ถ„๋ฐฐํ•˜์˜€๋‹ค. ํˆฌ์•ฝ๊ณผ์˜ค์œจ์€ JCAHO ์•ฝ๋ฌผ์‚ฌ์šฉ์—ฐ๊ตฌํŒ€์ด์•ฝ๋ฌผ์‚ฌ์šฉ์—๊ด€ํ•œ์งˆํ–ฅ์ƒ์š”์†Œ์ค‘๊ฐ€์žฅ์ค‘์š”ํ•œํ•ญ๋ชฉ์œผ๋กœํ•˜์˜€์œผ๋ฉฐ UDS ์‹ค์‹œ์˜์„ฑํŒจ๋ฅผํ‰๊ฐ€ํ•˜๋Š”์ค‘์š”ํ•œํ•ญ๋ชฉ์ด 2), 3) ๋‹ค. U.S Department of Health & Human Services์˜ Agency for Healthcare Research and Quality(AHRQ) ์—์„œ medication errors์—๋Œ€ํ•œ UDS์˜ํšจ๊ณผ๋ฅผํ‰๊ฐ€ํ•œ์—ฐ๊ตฌ๋“ค์„๋ณด๋ฉด (95% CI), Hynniman et al์€ํˆฌ์•ฝ๊ณผ์˜ค์œจ์ด UDS์—์„œ 3.5%(3.1-4.0%) ์ธ๋ฐ˜๋ฉด, ๊ธฐ์กด์˜ํˆฌ์•ฝ์‹œ์Šคํ…œ์ ์šฉ์ค‘์ธ๋‹ค๋ฅธ 4๊ณณ์˜๋ณ‘์›์—์„œ๊ฐ๊ฐ 8.3%(7.1-9.7%), 9.9%(8.0-12.2%),11.4%(9.9-13.2%), 20.6%(18.4-22.9%) ์˜€์Œ์„๋ณด๊ณ ํ•˜์˜€๋‹ค. 8) Schnell et al์˜์—ฐ๊ตฌ์—๋”ฐ๋ผ์บ๋‚˜๋‹ค 4๊ณณ์˜๋ณ‘์›์—์„œ์ „ํ–ฅ์ ์œผ๋กœ UDS ์ „, ํ›„์กฐ์‚ฌํ•˜์˜€์„๋•Œํˆฌ์•ฝ๊ณผ์˜ค์œจ์€ wrong time errors๋ฅผ์ œ์™ธํ•˜๋ฉด๋‘๊ตฐ๋ฐ๋ณ‘์›์—์„œ๋งŒ์œ ์˜์„ฑ์žˆ๋Š”๊ฐ์†Œ๋ฅผ๋ณผ์ˆ˜์žˆ์—ˆ๊ณ , ํ•œ๊ณณ์€์œ ์˜์„ฑ์—†์ด๊ฐ์†Œ, ๋‚˜๋จธ์ง€ํ•œ๊ณณ์€์˜คํžˆ๋ ค์œ ์˜์„ฑ์žˆ๊ฒŒ์ฆ๊ฐ€ํ•˜์˜€๋‹ค. ๋ณธ์—ฐ๊ตฌ์—์„œ๋Š”์‹ค์‹œ์ „ํˆฌ์•ฝ๊ณผ์˜ค๊ฑด์ˆ˜๊ฐ€ wrong time error 1๊ฑด์ด๊ณ ์‹ค์‹œํ›„์—๋Š”๋ฐœ์ƒํ•˜์ง€์•Š์•„์œ ์˜์„ฑ์žˆ๋Š”์ฐจ์ด๋ฅผ๋‚˜ํƒ€๋‚ด์ง€๋Š”์•Š์•˜๋Š”๋ฐ, ์ธก์ •๊ธฐ๊ฐ„์ด์ „, ํ›„ 2์ฃผ์ •๋„์˜๋ถˆ์ถฉ๋ถ„ํ•œ๊ธฐ๊ฐ„์ด์˜€๊ณ ๋Œ€์ƒํ™˜์ž์ˆ˜๋„์ ์–ด์„œํˆฌ์•ฝ๊ณผ์˜ค์œจ์—๋Œ€ํ•œํ‰๊ฐ€๋Š” UDS๊ฐ€์ „๋ณ‘๋™์œผ๋กœํ™•๋Œ€๋˜์–ด์ •์ฐฉ๋œ๋’ค์—ํ™•๋Œ€์‹ค์‹œํ•˜๋Š”๊ฒƒ์ด๋”์ •ํ™•ํ•œ๊ฒฐ๊ณผ๋ฅผ์–ป๋Š”๋ฐฉ๋ฒ•์œผ๋กœ์—ฌ๊ฒจ์ง„๋‹ค. ์กฐ์ œ์‹œ๊ฐ„์€ UDS bin์—์•ฝ๋ถ„๋ฆฌ, ๊ฐ์‚ฌ๋“ฑ์˜์—…๋ฌด์‹œ๊ฐ„์ดํ‰๊ท  42.6๋ถ„์ถ”๊ฐ€์ ์œผ๋กœ๋ฐœ์ƒํ•˜์˜€๋Š”๋ฐ๊ธฐ์กด์—ฐ๊ตฌ์—์˜ํ•˜๋ฉด UDS ์‹œํ–‰์‹œ๊ธฐ์กด์˜์กฐ์ œ์‹œ์Šคํ…œ์—๋น„ํ•ด 1.5๋ฐฐ์ˆ˜์˜์•ฝ์‚ฌ์™€ 2๋ฐฐ์ˆ˜์˜ํ…Œํฌ๋‹ˆ์…˜์ดํ•„์š”ํ•˜๋‹ค๊ณ ํ•œ๋‹ค. 1) ๊ทธ๋Ÿฌ๋‚˜๋ณธ์›์€์•ฝ๊ตญ์˜๊ธฐ์กด์‹œ์Šคํ…œ์œ ์ง€ํ•˜์—์„œ์‹œ๋ฒ”๋ณ‘๋™์—๋Œ€ํ•ด์„œ๋งŒ UDS๋ฅผ์‹ค์‹œํ•จ์—๋”ฐ๋ผ์—…๋ฌด์‹œ๊ฐ„์‚ฐ์ •๊ณ„์‚ฐ์—์–ด๋ ค์›€์ด์žˆ์—ˆ์œผ๋ฉฐ์ถ”ํ›„, ์ „ ๋ณ‘๋™์œผ๋กœ UDS๋ฅผ์‹ค์‹œํ• ๊ฒฝ์šฐ์ด์—์ ํ•ฉํ•œ์กฐ์ œ, ๊ฐ์‚ฌ์‹œ์Šคํ…œ์‹ค์‹œํ•˜์—์žฌํ‰๊ฐ€๊ฐ€์ด๋ฃจ์–ด์ ธ์•ผํ• ๊ฒƒ์ด๋‹ค. UDS ์‹ค์‹œ์—์•ž์„œ์‹ค์‹œํ•œ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ๋Š”์˜๋ฃŒ์ง„๊ณผ์•ฝ๊ตญ๊ณผ์˜๋งค๊ฐœ์—ญํ• ์„๋‹ด๋‹นํ•˜๋ฉด์„œ๋ณต์•ฝ์ƒ๋‹ด, ์ฒ˜๋ฐฉ์ค‘์žฌ๋“ฑ์˜์ž„์ƒ์—…๋ฌด๋กœํšจ์œจ์ ์ธํ™˜์ž๊ด€๋ฆฌ๋ฅผ์‹ค์‹œํ• ์ˆ˜์žˆ์—ˆ๋‹ค. ์ฒ˜๋ฐฉ์ค‘์žฌ๋ฐฉ๋ฒ•์—์žˆ์–ด์„œ๊ธฐ์กด์—๋Š”์˜๋ฃŒ์ง„์—๊ฒŒํ˜ธ์ถœ์ด๋‚˜์ „ํ™”๋ฅผ์ด์šฉํ–ˆ๋‹ค๋ฉด, ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ๋Š”๋ฉ”์ผ์ด๋‚˜์ง์ ‘์ค‘์žฌ์˜์ข€๋”๋‹ค์–‘ํ•œ๋ฐฉ์‹์„์ด์šฉํ•จ์œผ๋กœ์จ์ข€๋”์–‘์งˆ์˜์ฒ˜๋ฐฉ์ค‘์žฌ๋ฅผ์ˆ˜ํ–‰ํ• ์ˆ˜์žˆ์—ˆ๋‹ค. ๋ฏธ๊ตญ๋‚ด 15๊ฐœ๋ณ‘์›์—์„œ์กฐ์‚ฌํ•œ 2006 National Clinical Pharmacy Services Survey ๊ฒฐ๊ณผ๋ฅผ๋ณด๋ฉด์•ฝ์‚ฌ๋“ค์ด์ˆ˜ํ–‰ํ•˜๊ณ ์žˆ๋Š”์ž„์ƒ์—…๋ฌด๋Š”์•ฝ๋ฌผ์‚ฌ์šฉํ‰๊ฐ€, ๊ต์œก, ์•ฝ๋ฌผ๋ฐ๋…์„ฑ์ •๋ณด์ œ๊ณต, ์ž„์ƒ์—ฐ๊ตฌ, ๋ถ€์ž‘์šฉ๊ด€๋ฆฌ, ํ”„๋กœํ† ์ฝœ๊ด€๋ฆฌ, ํŒ€์˜๋ฃŒ์ฐธ์—ฌ, ์•ฝ๋ฌผ์š”๋ฒ•์ž๋ฌธ, CPR ํŒ€์ฐธ์—ฌ, ํšŒ์ง„์ฐธ์„, ์ž…์›ํ™˜์ž์˜์•ฝ๋ ฅ๊ด€๋ฆฌ์˜ patient-specific services๋กœ๋‹ค์–‘ํ•˜๋ฉฐ, ๋ณธ์—…๋ฌด๋“ค์„๋‹ค์ค‘ํšŒ๊ท€๋ถ„์„ํ•˜์˜€์„๋•Œ health care outcomes ๋Š”์ „์ฒด์ ์ธ mortality rate์˜๊ฐ์†Œ์—์˜ํ–ฅ์„๋ฏธ์น˜๋Š”์š”์†Œ๋“ค์ด๋งŽ์•˜๋‹ค. 9) ํ˜„์žฌ, ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ๋„ํ™˜์ž์น˜๋ฃŒ์˜์งˆํ–ฅ์ƒ์„์œ„ํ•ด์–‘์งˆ์˜์ฒ˜๋ฐฉ์ค‘์žฌ์—…๋ฌด๋ฅผ์ˆ˜ํ–‰ํ•˜๋ฉด์„œ์ œ๊ณต๋œ์ž„์ƒ์—…๋ฌด์˜์ •ํ™•์„ฑ, ๊ฒฝ์ œ์„ฑ๋“ฑ์˜ํ‰๊ฐ€๋ฐฉ๋ฒ•๊ณผ์•ฝ์‚ฌ๊ฐ€์˜์‚ฌ์˜์•ฝ๋ฌผ์น˜๋ฃŒ๋ฐํ™˜์ž์น˜๋ฃŒ์—์˜ํ–ฅ์„๋ฏธ์นœ์ •๋„๋ฅผ์ธก์ •ํ• ์ˆ˜์žˆ๋Š”๋ฐฉ๋ฒ•์„์ฐพ์•„์ˆ˜์น˜ํ™”ํ•˜๋Š”๊ฒƒ์ด๋˜ํ•œ, ์ค‘์š”๊ณผ์ œ์ด๋‹ค. ๋ณธ์—ฐ๊ตฌ์—์„œ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์™€ UDS๋ฅผ์‹ค์‹œํ•˜๋ฉด์„œ๋‹ค์–‘ํ•œํ‰๊ฐ€์ง€ํ‘œ๋ฅผ์„ ์ •ํ•˜์—ฌ๊ฐœ์„ ํšจ๊ณผ๋ฅผ๋„์ถœํ•˜์˜€๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ UDS ์‹ค์‹œ๊ธฐ๊ฐ„์ด์งง์•˜๋˜๊ด€๊ณ„๋กœ์žฅ๊ธฐ๊ฐ„์˜ํ‰๊ฐ€์‹œ๊ธฐ๋ฅผ๊ฐ€์งˆ์ˆ˜์—†์—ˆ๊ณ ์‹ค์‹œ๋ณ‘๋™์ด์ œํ•œ์ ์ด์–ด์„œ๋ณ‘๋™์˜ํŠน์„ฑ์—๋”ฐ๋ฅธ์˜ํ–ฅ์„๋ฐ›์„์ˆ˜์žˆ์—ˆ๋‹ค. ํ–ฅํ›„, ํ™•๋Œ€์‹œํ–‰์‹œ์ •์ฐฉ๋œ์‹œ์Šคํ…œ์„๊ธฐ๋ฐ˜์œผ๋กœ๊ฐ๊ด€์ ์ธ UDS ํ‰๊ฐ€๊ฐ€๊ฐ€๋Šฅํ•˜๋ฆฌ๋ผ์ƒ๊ฐ๋œ๋‹ค. ๊ฒฐ๋ก  UDS์™€๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์‹ค์‹œ๊ฒฐ๊ณผ๋กœ์ •๊ทœ์ฒ˜๋ฐฉ์ค‘์‹ฌ์˜์ฒ˜๋ฐฉ๋ฐœํ–‰๊ณผํˆฌ์•ฝ์ ์šฉ์‹œ์ ๋ณ€๊ฒฝ๋“ฑ์˜์ฒ˜๋ฐฉํ”„๋กœ์„ธ์Šค์ •๋ฆฝํ™”์™€์ด๋ฃจ์–ด์กŒ์œผ๋ฉฐ, ๋ณ‘๋™๋น„ํ’ˆ์•ฝ์ œ์˜ํšจ์œจ์ ๊ด€๋ฆฌ์™€๊ฐ„ํ˜ธํˆฌ์•ฝ๊ด€๋ จ์—…๋ฌด์‹œ๊ฐ„๊ฐ์†Œ๋ฅผ๊ฐ€์ ธ์™”๊ณ ํˆฌ์•ฝ๊ณผ์˜ค๊ด€๋ฆฌ๋“ฑ์˜๊ฐœ์„ ํšจ๊ณผ๋ฅผ์–ป์„์ˆ˜์žˆ์—ˆ๋‹ค. ๋˜ํ•œ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ๋Š” UDS ์‹ค์‹œ์—๋”ฐ๋ฅธํ•„์ˆ˜์ ์ธ์ž„์ƒ์•ฝ - 70 -

์šฐ์ง€์œค : Unit Dose System ์„ํ†ตํ•œ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜์—…๋ฌดํ™œ๋™ ์‚ฌ๋กœ์„œ์•ฝ๋ ฅ๊ด€๋ฆฌ๋ฅผํ†ตํ•œ์ฒ˜๋ฐฉ์ค‘์žฌํ™œ๋™๊ณผ๋‹ค์–‘ํ•œ์ž„์ƒํ™œ๋™์„ํ†ตํ•ดํ™˜์ž์น˜๋ฃŒ์˜์งˆ์„ํ–ฅ์ƒ์‹œํ‚ค๊ณ ๋ณ‘๋™๊ณผ์˜์›ํ™œํ•œ์˜์‚ฌ์†Œํ†ต์—์ค‘๊ฐœ์—ญํ• ์„๋‹ด๋‹นํ•˜๊ณ ์žˆ๋‹ค. ํ–ฅํ›„ UDS ํ™•๋Œ€์‹ค์‹œ์‹œ๋ณ‘๋™์ „๋‹ด์•ฝ์‚ฌ์˜ํ™œ๋™์„ํ†ตํ•œ์ž„์ƒ์•ฝ์‚ฌ์˜์—ญํ• ์ •๋ฆฝ๊ณผํ™•๋Œ€๋ฐํ™˜์ž์ค‘์‹ฌ์˜์•ฝ๋ฃŒ์‹ค์ฒœ์„๊ธฐ๋Œ€ํ• ์ˆ˜์žˆ๊ฒ ๋‹ค. ์ฐธ๊ณ ๋ฌธํ—Œ 1) ์ด๋ฏผ์‹. UNIT DOSE SYSTEM ๋„์ž…์ „๋ง. J Kor Soc Hosp Pharm. 1999;16(2):269-273. 2) ์ด์ˆœ์‹ค. ์ž…์›ํ™˜์ž์„œ๋น„์Šค์—๋Œ€ํ•œ๋Œ€์‘๋ฐฉ์•ˆ - Unit Dose System-. J Kor Soc Hosp Pharm.2000;17(1):40-54. 3) ์ด์ˆœ์‹ค. ์˜์•ฝ๋ถ„์—…์ดํ›„๋ณ‘์›์•ฝ๊ตญ์—…๋ฌด๋ณ€ํ™” II Unit Dose System-. J Kor Soc HospPharm. 2001;18(1):1-10. 4) Pelligrino, E. D. The unit dose system. JAMA. 1968;205(8):585. 5) Darryl S. Rich. New JCAHO Medication Management Standards for 2004. Am J Health-Syst Pharm. 2004;61(13):1349-1358. 6) ๋ฏผ์ผ๊ธฐ. ๋ฏธ๊ตญ๋ณ‘์›์•ฝ์‚ฌ์˜ํ˜„์žฌ์™€์•ž์œผ๋กœ์˜์ถ”๊ตฌ๋ฐฉํ–ฅ. J Kor Soc Hosp Pharm. 2003;20(4):406-411. 7) ์ด์€์ˆ™๋“ฑ. ์ „๋ณ‘๋™ UDS ๋„์ž…์„ํ†ตํ•œ์ž…์›ํ™˜์ž์ฒ˜๋ฐฉ์กฐ์ œ๋ฐ์•ฝ์‚ฌ์˜๋ณ‘๋™ํ™œ๋™ํšจ์œจํ™”๋ฐฉ์•ˆ. J Kor Soc Hosp Pharm. 2004;21(4):371-388.8)http://www.ahrq.gov/clinic/ ptsafety/chap10.htm 9) Bond, C. A. and C. L. Raehl. 2006 national clinical pharmacy services sur vey: clinical pharmacy services, collabo rative drug management, medication errors, and pharmacy technology. Pharmacotherapy. 2008;28(1): 1-13. - 71 -